What are genome-wide association studies telling us about B-cell tumor development?

Amy L Sherborne; Richard S Houlston

doi:10.18632/oncotarget.169

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Perspectives:

What are genome-wide association studies telling us about B-cell tumor development?

Amy L Sherborne _ and Richard S Houlston

PDF | HTML | How to cite

Oncotarget. 2010; 1:367-372. https://doi.org/10.18632/oncotarget.169

Metrics: PDF 2643 views | HTML 3060 views | ?

Abstract

Received: August 9, 2010, Accepted: August 16, 2010, Published: September 11, 2010

It has long been speculated that common genetic variation influences the development of B-cell malignancy, however until recently evidence for this assertion was lacking. The advent of genome-wide association studies (GWAS) has allowed the search for this class of susceptibility allele to be conducted on a genome-wide basis. Recent GWAS of chronic lymphocytic leukemia (CLL) and acute lymphoblastic leukemia (ALL) have identified novel disease genes for CLL and ALL and underscore the importance of polymorphic variation in B-cell development genes as determinants of leukemia risk.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 169

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Perspectives:

What are genome-wide association studies telling us about B-cell tumor development?

Abstract